Did you know that weight-loss drugs might have the potential to heal the habit of substance abuse?In a recent study published ...

Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.

A recent scientific study published in the Oman Medical Journal revealed a significant increase in emergency department ...

US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that may mimic GLP-1 drugs for years after ...

Changes in purchasing patterns after glucagon-like peptide-1 receptor agonist (GLP-1RA) initiation were seen across most nutrient ...

Losing weight is best done with medical supervision.

Bunnie XO shares her harrowing experience with an experimental weight-loss drug, describing severe depression and suicidal ...

GLP-1 RA use is associated with improved survival and lower hospitalization rates in patients with type 2 diabetes receiving cancer therapy.

Drugs like Ozempic already have a big impact on how much patients eat - and now they may be changing the way they shop and ...

By Tarun Sai Lomte An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing ...

GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.